CardioNet has appointed Joseph Capper as president and CEO, effective immediately. He will succeed Randy Thurman who remains as chairman of the board of directors.
Mr Capper was previously president, CEO and member of the board of directors of Home Diagnostics, a developer, manufacturer and marketer of diabetes management products.
Mr Capper had joined Home Diagnostics in 2009 and positioned the company for a strategic merger in a transaction that created substantial value to its stakeholders.
Prior to Home Diagnostics, Mr Capper was president and CEO of CCS Medical, a provider of medical supplies in diabetes, wound care, respiratory and other therapeutic categories.
Mr Capper said: “I am excited to have this tremendous opportunity to join CardioNet and work with the outstanding team that Randy has put in place. CardioNet’s MCOT system has been gaining traction in the medical community as the leading wireless technology for monitoring cardiac arrhythmias and is one of the most innovative technologies in healthcare.
“I look forward to utilizing my years in the medical diagnostic arena to drive MCOT adoption and leverage our platform to build the leading company in wireless medicine.”
Mr Thurman said, “After a thorough and comprehensive search, CardioNet was fortunate to identify Joe as an excellent candidate with the experience and track record to join CardioNet as our president and CEO. Joe brings an outstanding background as CEO of medical diagnostic companies and has an excellent foundation in sales from his early Bayer experience.
“As importantly, Joe has established himself as a strategically-oriented leader with a history of generating results and stakeholder value. His corporate and military background demonstrates his hands-on approach, strong sense of character, values and ability to lead organizations. CardioNet’s technology, strong balance sheet and leadership in its industry are well served by Joe’s appointment as CEO.”